FIELD: chemistry.
SUBSTANCE: described is a compound of formula
or its pharmaceutically acceptable salt, where m, p, q, Ar, R1 and R2 are as given in the description, as well as a pharmaceutical composition with selective affinity to 5-HT receptors which contains a formula (I) compound.
EFFECT: obtained compounds have selective affinity to 5-HT receptors and can be used, as expected, in treating certain central nervous system disorders.
21 cl, 1 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
TETRALINE AND INDANE DERIVATIVES AND USE THEREOF | 2005 |
|
RU2389723C2 |
TETRALINE AND INDAN DERIVATIVES AND APPLICATION THEREOF | 2005 |
|
RU2396255C2 |
CHROMAN DERIVATIVES AND APPLICATIONS THEREOF IN TREATING CNS DISORDERS | 2005 |
|
RU2396266C2 |
2,5-SUBSTITUTED TETRAHYDROISOQUINOLINE AND A PHARMACEUTICAL MODULATION COMPOSITION 5-НТ6 | 2004 |
|
RU2327689C2 |
INDOLE DERIVATIVES SHOWING AFFINITY TO 5-HT RECEPTORS | 2002 |
|
RU2294932C2 |
KINASE INHIBITORS | 2012 |
|
RU2623734C9 |
METHOD OF SYNTHESISING DERIVATIVES OF AMINO-METHYL TETRALIN | 2009 |
|
RU2512285C2 |
4-PYPERAZINYL-BENZEN-SULFANYLINDOLES WITH AFFINITY TO 5-HT6 RECEPTOR | 2003 |
|
RU2324693C2 |
NON-PEPTIDE ANTAGONISTS GnRH | 2003 |
|
RU2329251C2 |
BENZIMIDAZOLE AND INDOLE DERIVATIVES AS SELECTIVE 5-HT6 AND/OR 5-HT2A RECEPTOR ANTAGONISTS | 2006 |
|
RU2415138C2 |
Authors
Dates
2010-05-10—Published
2005-12-12—Filed